XML 22 R16.htm IDEA: XBRL DOCUMENT v3.25.1
Equity Incentive Plan
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Equity Incentive Plan . Equity Incentive Plan

Option Plan Activity

The following table summarizes the stock option activity for the three months ended March 31, 2025:

 

 

 

Shares
(in thousands)

 

 

Weighted-
Average
Exercise Price

 

 

Weighted-
Average
Remaining
Contractual
Term (Years)

 

Outstanding at December 31, 2024

 

 

26,082

 

 

$

4.46

 

 

 

7.80

 

Granted

 

 

4,461

 

 

$

1.70

 

 

 

 

Exercised

 

 

(99

)

 

$

1.38

 

 

 

 

Expired and forfeited

 

 

(982

)

 

$

5.67

 

 

 

 

Outstanding at March 31, 2025

 

 

29,462

 

 

$

4.02

 

 

 

7.69

 

 

We estimated the fair value of each option grant on the grant date using the Black-Scholes option pricing model and for market-based stock option grants using the Monte Carlo simulation model. The following are the weighted-average assumptions:

 

 

 

For the Three Months Ended

 

 

 

March 31,

 

 

 

2025

 

 

2024

 

Risk-free interest rate

 

 

4.3

%

 

 

4.2

%

Dividend yield

 

 

0.0

%

 

 

0.0

%

Volatility

 

 

80.1

%

 

 

79.7

%

Expected life (years)

 

 

6

 

 

 

4

 

 

The following table summarizes the restricted stock unit (“RSU”) activity for the three months ended March 31, 2025:

 

 

 

Shares
(in thousands)

 

 

Weighted-Average Grant Date Fair Value

 

Outstanding at December 31, 2024

 

 

1,981

 

 

$

2.35

 

Granted

 

 

2,207

 

 

$

1.70

 

Released

 

 

(173

)

 

$

1.82

 

Expired and forfeited

 

 

(163

)

 

$

2.66

 

Outstanding at March 31, 2025

 

 

3,852

 

 

$

1.93

 

 

The fair value of RSUs is estimated based on the closing market price of our common stock on the date of the grant. RSUs generally vest quarterly over a four-year period.

Stock-Based Compensation

The following table summarizes stock-based compensation expense related to stock-based payment awards granted pursuant to all of our equity compensation arrangements (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

 

2025

 

 

2024

 

 

General and administrative

 

$

1,572

 

 

$

1,878

 

 

Sales and marketing

 

 

695

 

 

 

796

 

 

Research and development

 

 

244

 

 

 

701

 

 

Total stock-based compensation expense

 

$

2,511

 

 

$

3,375

 

 

 

 

As of March 31, 2025, there was $25.5 million of total unrecognized compensation cost related to non-vested, stock-based payment awards granted under all of our equity compensation plans and all non-plan option grants. Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures. We expect to recognize this compensation cost over a weighted-average period of three years.